✦ LIBER ✦

Poster 48: Gastrointestinal Tolerability of Tapentadol Extended Release in Patients With Chronic Low Back Pain: Results of a Randomized, Double-blind, Active- and Placebo-controlled Phase 3 Study

✍ Scribed by Douglas Shapiro; Robert Buynak; Mila S. Etropolski; Claudia Lange; Akiko Okamoto; Ilse Van Hove

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety, and gastrointestinal t

✍ R. Buynak; D. Shapiro; A. Okamoto; C. Lange; M. Etropolski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Efficacy and safety of tapentadol ER for

✍ R. Buynak; D. Shapiro; A. Okamoto; I. Van Hove; M. Etropolski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Efficacy and safety of oxymorphone exten

✍ Martin E. Hale; Chris Dvergsten; Joseph Gimbel 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 180 KB

A randomized, double-blind, placebo- and

✍ M. Etropolski; C. Rauschkolb-Löffler; D. Shapiro; A. Okamoto; C. Lange 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Efficacy and tolerability of tapentadol

✍ A. Vinik; D. Shapiro; C. Rauschkolb-Löffler; B. Lange; K. Karcher; D. Pennett; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 38 KB

(250) Oxymorphone extended release in hy

✍ M. Hale; T. Ma; H. Ahdieh; R. Kerwin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 40 KB